Krupka, C
Kufer, P
Kischel, R
Zugmaier, G
Lichtenegger, F S
Köhnke, T
Vick, B
Jeremias, I
Metzeler, K H
Altmann, T
Schneider, S
Fiegl, M
Spiekermann, K
Bauerle, P A
Hiddemann, W
Riethmüller, G
Subklewe, M
Article History
Received: 29 May 2015
Revised: 6 July 2015
Accepted: 10 July 2015
First Online: 4 August 2015
Competing interests
: PK, RK and GZ are employed by AMGEN Research (Munich) GmbH. PK, RK, GZ, PAB and GR were involved in invention and development of the antibody and are shareholders of Amgen Research GmbH. PAB was employed by AMGEN Research at the time the data were generated. The study was supported by funding from AMGEN Research GmbH and Gert Riethmüller (Emeritus from the Institute for Immunology, Ludwig-Maximilians-University, Munich, Germany). The remaining authors declare no conflict of interest.